WDL
BMY icon

Well Done LLC’s Bristol-Myers Squibb BMY Stock Holding History

Well Done LLC’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-584
Closed -$30K – 205
2018
Q4 		$30K Buy
+584
New +$31.4K 0.01% 303
2018
Q2 		– Sell
-570
Closed -$36K – 170
2018
Q1 		$36K Buy
+570
New +$36.7K 0.01% 257

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Well Done LLC's BMY Position: Q1 2019 in Review

Well Done LLC sold out of Bristol-Myers Squibb (BMY) in Q1 2019, closing a stake of 584 shares — an estimated $30K sold.

Well Done LLC first reported a position in BMY in Q1 2018 and held it in 2 quarters. The position peaked at $36K in Q1 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q1 2019.

  • Well Done LLC reported no remaining Bristol-Myers Squibb position as of Q1 2019 after selling out during the quarter.
  • Well Done LLC sold 584 Bristol-Myers Squibb shares in Q1 2019, an estimated $30K.
  • Well Done LLC first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 2 quarters.
  • Well Done LLC's Bristol-Myers Squibb position peaked at $36K in Q1 2018.
  • 1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2019.

Based on Well Done LLC's 13F filing for Q1 2019, filed 9 May 2019.